AzTrials
AzTrials

Smoking CessationNCT05958667

Quitxt Mobile Text Messaging Cessation Research Study

A study testing Quitxt text messaging or Chat in people with Smoking Cessation, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The health benefits of smoking cessation by age 30 are much greater than cessation later in life, including gaining 10 years of life, compared with those who continue to smoke. The goal of the proposed study is to evaluate the effectiveness of the bilingual and culturally tailored Quitxt mobile cessation intervention. Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
Quitxt text messaging or Chat
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,200 participants
Where
1 siteUnited States
Study dates
12 Feb 2026to Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Latinos
  • aged 18-29 years;
  • smoking at least one cigarette/day ≥3 days/week;
  • interested in quitting;
  • willing to provide follow-up data;
  • are not simultaneously participating in a cessation program;
Show all 10Show fewer
  • own a cell phone or smartphone;
  • are able to send and receive text messages and access the Internet;
  • reside in the study area; and
  • able to provide informed consent to participate in the study.

Who cannot join

  • are not interested in quitting;
  • are unable to provide consent due to a mental, emotional, or physical handicap that keep them from understanding the consent information;
  • do not own a cell phone with text and Internet capabilities;
  • are unable to respond to text messages and questions or unable to view the study mobile webpages/YouTube videos (i.e., if they are blind, deaf); or
  • are planning to move from the study area within the study time span.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Patricia Chalela, DrPH contact

(210) 562-6513

chalela@uthscsa.edu

Vivian Cortez, MS contact

(210) 562-6528

cortezv1@uthscsa.edu

United States1 site, 1 recruiting
  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas, 78229

    Patricia Chalela, DrPH, 210-562-6513, chalela@uthscsa.edu

    Recruiting

Other trials in United States

About this study

Official title: Randomized Controlled Trial to Assess Innovative Smoking Cessation Services for Young Adults in Texas

The health benefits of smoking cessation by age 30 are much greater than cessation later in life, including gaining 10 years of life, compared with those who continue to smoke. The goal of the proposed study is to evaluate the effectiveness of the bilingual and culturally tailored Quitxt mobile cessation intervention. Quitxt provides interactive messages through texts or chat with visual and video content employing theory- and evidence-based techniques to prompt and sustain cessation. The study will recruit 1,200 Latino young adult smokers aged 18-29 who enroll and agree to make quit attempts, with half randomly assigned (like flipping a coin) to receive Quitxt and half to abbreviated text messages with smoking cessation-related content and referral to the Texas Department of State Health Services cessation program Yes Quit (which has diverse formats, but not explicitly tailored for young Latino adults in South Texas). Participants respond to baseline and follow-up assessments at one, three and six months after their enrollment, and those who report cessation will be asked to provide saliva samples to confirm they quit smoking. The sample size will be sufficient to detect expected higher cessation rates in those who are enrolled in Quitxt than those who are enrolled in Texas DSHS Yes Quit. The investigators will publish results in scientific journals, report them at scientific and community meetings, share them on social media, and publicize them widely. This study has the potential to advance public health by evaluating the effectiveness of a scalable, easily disseminated and adaptable intervention to help young adults, especially Latinos, quit smoking and reduce smoking-related cancer and chronic disease morbidity and mortality and their associated healthcare costs.

Read the detailed description

Despite major advances in tobacco control and treatment, tobacco use remains the single largest preventable cause of morbidity and mortality in the US. Smoking prevalence is highest among Texas young adults (ages 18-29) and even higher among those with less than a high-school education and those living in rural areas and at or below the poverty level, such as Latinos. About 19.2% of Latinos ages 18-29 in the study areas are current smokers placing them at higher risk of cancer and other tobacco-related morbidity and mortality. Young adults are heavy users of smartphones, text messaging, social media chats and other mobile social media, providing a remarkable opportunity for innovation in the delivery of health promotion services to reduce health disparities in this large and rapidly growing racial/ethnic population. New social media have an extraordinary theoretical potential for assisting smoking cessation by providing peer modeling and eliciting social reinforcement for behavior change. The goal of this project is to experimentally evaluate Quitxt, a culturally appropriate mobile smoking cessation program. Quitxt - launched by an interdisciplinary research team using proven social cognitive, motivational interviewing, and brief intervention methods for promoting behavior change - blends bilingual text and social media messaging for smoking cessation tailored to the language and culture of young adult smokers in the vulnerable region of South Texas. Quitxt has not been tested in a research study, as its creation as an evidence-based cancer prevention service for young adult smokers was supported by the Cancer Prevention and Research Institute of Texas (CPRIT). To study the effects of Quitxt, the study team will recruit 1,200 young adult (ages 18-29) Latino Spanish- and English-speaking smokers over the 5-year study interval in South Texas. A two-group parallel randomized controlled trial will be conducted to compare rates of smoking cessation: 1) the intervention group will receive the innovative Quitxt text messaging or the chat mobile service; and 2) the usual care group will receive abbreviated text messaging with smoking cessation-related content and referral to the Texas Department of State Health Services (TDSHS) cessation program Yes Quit (www.yesquit.org). The investigators will measure effects online at time of enrollment and again at one, three and six months later. The investigators will validate reports of smoking cessation via biological tests, for those who report smoking cessation at one, three and six-month follow-ups. The investigators hypothesize that the group receiving the Quitxt intervention will achieve significantly higher smoking cessation rates than the group receiving usual care. This study will expand research on the health of young adult Latinos by testing an innovative, mobile, culturally, and linguistically appropriate intervention to reduce smoking among young adult Latino smokers by enhancing their skills development, competence, and self-efficacy to initiate and maintain cessation. Moreover, this study will advance public health by testing the effectiveness of a scalable, evidence-based, easily disseminated, and adaptable intervention with potentially broad national reach to help young adults stop smoking and reduce smoking-related cancer and chronic disease morbidity and mortality and their associated healthcare costs.

Being tested
Quitxt text messaging or Chat, Usual care
Keywords
Quitxt, Young adults, Latinos
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quitxt text messaging or ChatBehavioural

    Also called Culturally appropriate mobile smoking cessation proram

    Mobile intervention using proven social cognitive, motivational interviewing, and brief intervention methods for promoting behavior change - blends bilingual text and social media messaging for smoking cessation tailored to the language and culture of young adult smokers in our vulnerable region of South Texas.

  • Usual careOther

    Also called Abbreviated text messaging with smoking cessation-related content

    Abbreviated text messaging with smoking cessation-related content and referral to the Texas Department of State Health Services (TDSHS) cessation program Yes Quit.

Study groups in NCT05958667
Study groupRoleWhat they receive
Quitxt bilingual text messaging and chatExperimentalCulturally and linguistically tailored, bilingual text messaging or chat mobile app. Our text messaging or chat intervention will include messaging options in which users can text or message a code when they are craving a cigarette or at risk of relapse and immediately receive text or social media messages to help them avoid smoking. The social media content also will include opportunities for users to repeatedly visit key content pages and receive immediate support when experiencing cravings, stress, bad mood, or when feeling at risk of smoking.
Receives: Behavioral: Quitxt text messaging or Chat
Usual careOtherAbbreviated text messaging with smoking cessation-related content and referral to the Texas Department of State Health Services (TDSHS) cessation program Yes Quit (www.yesquit.org) available to smokers seeking help quitting. The abbreviated text messaging will include general information on smoking harms and benefits of cessation, and baseline data collection and follow-up assessments.
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Smoking cessation

    Measure of smoking cessation (7-day point prevalence abstinence)self-reported and biochemically verified.

    Measured: 6 months

Secondary outcomes (1)
  1. Smoking cessation assessment

    Measure of smoking cessation (7-day point prevalence abstinence)self-reported and biochemically verified.

    Measured: 1 month and 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2023
  2. Study start12 Feb 2026
  3. Primary completionAug 2028 (estimated)
  4. Study completionAug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
A two-group parallel randomized controlled trial with 1,200 Spanish- and English-speaking young Latino adult smokers in South Texas (ages 18-29) to assess the effects of Quitxt on smoking cessation.
Masking
None (open label)
Enrolment
1,200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05958667
Sponsor's protocol ID
HSC20230473H
Status last verified
Mar 2026
First submitted
14 Jul 2023
Last updated
31 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Annual presentation at a national conference is expected. Community Presentations/Forums for young adult organizations and groups, public health and clinical practitioners, and the community at large. Educational presentations and infographics about the importance of quitting smoking aimed at colleges, technical schools, community stakeholders, at health fairs or at in-person and/or virtual educational sessions organized with the study team's community partners. Submission to scientific journals Communications, American Journal of Health Promotion, Tobacco Control, and other scientific periodicals to disseminate findings including Quitxt text messaging and chat development and implementation and report experimental results based on follow-up assessments. Via the Institute for Health Promotion Research home website; its institutional e-newsletters; and its Salud America! (SA!) national network.

Questions about this trial

What is this clinical trial studying?

A study testing Quitxt text messaging or Chat in people with Smoking Cessation, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 31 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Patricia Chalela, DrPH ((210) 562-6513, chalela@uthscsa.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Smoking cessation (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in